BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28544627)

  • 1. Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts.
    Baulida J
    Mol Oncol; 2017 Jul; 11(7):847-859. PubMed ID: 28544627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET.
    Goossens S; Vandamme N; Van Vlierberghe P; Berx G
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):584-591. PubMed ID: 28669750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Post-Translational Regulation of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis.
    Kang E; Seo J; Yoon H; Cho S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.
    Kahlert UD; Joseph JV; Kruyt FAE
    Mol Oncol; 2017 Jul; 11(7):860-877. PubMed ID: 28556516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilayer control of the EMT master regulators.
    Zheng H; Kang Y
    Oncogene; 2014 Apr; 33(14):1755-63. PubMed ID: 23604123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic roles of EMT-inducing transcription factors.
    Puisieux A; Brabletz T; Caramel J
    Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy.
    Baulida J; GarcĂ­a de Herreros A
    Biochim Biophys Acta; 2015 Aug; 1856(1):55-61. PubMed ID: 26050961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
    Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
    Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT-ions with a TWIST between EMT and MET.
    Tang H; Massi D; Hemmings BA; MandalĂ  M; Hu Z; Wicki A; Xue G
    Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
    Kaller M; Hermeking H
    Adv Exp Med Biol; 2016; 937():71-92. PubMed ID: 27573895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
    Lee JY; Kong G
    Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
    Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
    J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
    Mishra VK; Johnsen SA
    Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory fibroblasts in cancer.
    Lim H; Moon A
    Arch Pharm Res; 2016 Aug; 39(8):1021-31. PubMed ID: 27384063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
    Cho ES; Kang HE; Kim NH; Yook JI
    Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.
    Lee SJ; Yang CS; Kim DD; Kang YN; Kwak SG; Park JB; Cho CH; Park KK
    Int J Clin Exp Pathol; 2015; 8(11):14270-82. PubMed ID: 26823743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loop.
    Alidadiani N; Ghaderi S; Dilaver N; Bakhshamin S; Bayat M
    Gene; 2018 Oct; 674():115-120. PubMed ID: 29936265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.